Sedia Biosciences
Manufacturing · Oregon, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9590 SW Gemini Dr, Beaverton, Oregon, 97...Phone Number
(503) 459-4159Website
www.sediabio.comRevenue
$5.9 MillionIndustry
About Sedia Biosciences
Sedia Biosciences Org Chart
Is Sedia Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sedia Biosciences has new funding data
Sedia Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sedia Biosciences launches new products
Earning: See what the market has to say on Sedia Biosciences recently announced quarterly report
Check if Sedia Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sedia Biosciences had a recent Job posting/layoffs
Check out if Sedia Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Sedia Biosciences
Recommended Actions
Find VP level buyers at Sedia Biosciences
Find 2 more new buyers
Compare Similar Companies to Sedia Biosciences
Compare insights from companies similar to Sedia Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sedia Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sedia Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sedia Biosciences.
Sedia Biosciences financials insights
Gather financial insights about Sedia Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Grant
$195K
Debt
$350K
Sedia Biosciences Tech Stack
A closer look at the technologies used by Sedia Biosciences
Sedia Biosciences News & Media
Sedia Biosciences Announces ISO 13485 Certification for Production of HIV In Vitro Diagnostics Tests
Beaverton Oregon Facilities Certified with International Quality Standard BEAVERTON, OREGON, UNITED STATES, February 3, 2022 /EINPresswire.com/ -- Sedia Biosciences Corporation today announced that it has received ISO 13485:2016 Certification of its …Sedia Biosciences Announces COVID-19 Whole Genome Sequencing Service for Novel Variant Detection and Surveillance
BEAVERTON, OREGON, UNITED STATES, April 29, 2021 /EINPresswire.com/ -- Sedia Biosciences Corporation today announced the launch of a new service, “Sedia® COVID-19 WGS”, offering whole genome sequencing of SARS-CoV-2 samples for novel variant detection …Sedia Biosciences Board Announces Changes to Executive Leadership
BEAVERTON, Ore., Feb. 3, 2021 /PRNewswire/ -- Roger I. Gale, previously Chief Executive Officer and Chairman of the Board of Directors, was appointed Executive Chairman of Sedia. Mr. Gale is a co-founder of Sedia. Dr. Lynn Stevenson, Member of the Board of Directors, said, "Mr. Gale has...Sedia Biosciences Corporation announces expansion and move to new research and manufacturing facility in Beaverton, Oregon, USA
BEAVERTON, Ore., July 30, 2020 /PRNewswire/ -- Sedia Biosciences Corporation, formerly of Portland Oregon, today announced the relocation to and opening of their new assay development and manufacturing facility in Beaverton, Oregon. The 27,000 square foot facility provides for both...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sedia Biosciences
Sedia Biosciences is a privately held medical device and diagnostics company, founded in 2009 and based in Beaverton, Oregon, USA. The company's commitment is to become a leader in advancing global access to care through the creation of: (1) state-of-the-art rapid point-of-care diagnostic assays, (2) novel epidemiological disease surveillance assay... Read More